Akbay EA et al. |
D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice. |
2014 |
Genes Dev. |
pmid:24589777
|
Pusch S et al. |
D-2-Hydroxyglutarate producing neo-enzymatic activity inversely correlates with frequency of the type of isocitrate dehydrogenase 1 mutations found in glioma. |
2014 |
Acta Neuropathol Commun |
pmid:24529257
|
Menendez JA et al. |
Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites. |
2014 |
Cell Cycle |
pmid:24526120
|
Borger DR et al. |
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma. |
2014 |
Clin. Cancer Res. |
pmid:24478380
|
Işıkay S et al. |
A child with L-2 hydroxyglutaric aciduria presenting with dilated cardiomyopathy: coincidence or a new syndrome? |
2014 |
Anadolu Kardiyol Derg |
pmid:24382499
|
Terunuma A et al. |
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. |
2014 |
J. Clin. Invest. |
pmid:24316975
|
Gilbert MR et al. |
Autophagy and oxidative stress in gliomas with IDH1 mutations. |
2014 |
Acta Neuropathol. |
pmid:24150401
|
Lu C et al. |
Induction of sarcomas by mutant IDH2. |
2013 |
Genes Dev. |
pmid:24065766
|
Chaumeil MM et al. |
Non-invasive in vivo assessment of IDH1 mutational status in glioma. |
2013 |
Nat Commun |
pmid:24019001
|
McKenney AS and Levine RL |
Isocitrate dehydrogenase mutations in leukemia. |
2013 |
J. Clin. Invest. |
pmid:23999441
|